Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Nevanimibe hydrochloride | 133825-81-7 | 99.5% | 458.08 g·mol⁻¹ | C27H40ClN3O | 100 MG
SDP

Catalog No. 5000214054
Encompass_Preferred

Nevanimibe hydrochloride is an orally active, selective inhibitor of acyl-coenzyme A:cholesterol O-acyltransferase 1 (ACAT1) used in preclinical research. It has low-nanomolar activity against ACAT1 and has been investigated in cell models for effects on cholesterol metabolism and adrenocortical cancer.

  • Selective ACAT1 inhibitor with EC50 ≈ 9 nM.
  • Orally active small molecule suitable for in vitro and in vivo research.
  • High chemical purity (~99.5%) for reliable experimental results.
  • Available as solid and as 10 mM solution in DMSO for flexible dosing.
  • Characterized by CAS 133825-81-7 and molecular weight 458.08 g·mol⁻¹.

Catalog No. 50-002-14054 Supplier Medchemexpress LLC Supplier No. HY100399A100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Nevanimibe hydrochloride is an orally active, selective inhibitor of acyl-coenzyme A:cholesterol O-acyltransferase 1 (ACAT1) used in preclinical research. It has low-nanomolar activity against ACAT1 and has been investigated in cell models for effects on cholesterol metabolism and adrenocortical cancer.

  • Selective ACAT1 inhibitor with EC50 ≈ 9 nM.
  • Orally active small molecule suitable for in vitro and in vivo research.
  • High chemical purity (~99.5%) for reliable experimental results.
  • Available as solid and as 10 mM solution in DMSO for flexible dosing.
  • Characterized by CAS 133825-81-7 and molecular weight 458.08 g·mol⁻¹.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.